Title |
Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction
|
---|---|
Published in |
Chinese Medicine, June 2010
|
DOI | 10.1186/1749-8546-5-22 |
Pubmed ID | |
Authors |
Tsai-Hui Lin, Ching-Liang Hsieh |
Abstract |
Danshen, the dried root of Salvia miltiorrhiza, is a Chinese medicine used to promote blood flow and treat vascular disease. The present article reviews the pharmacological effects of Danshen on cerebral infarction and possible interactions between Danshen and Western drugs. Danshen may reduce or prolong the development of atherosclerosis and may have anti-hypertensive and anti-platelet aggregation effects, which prevent cerebral infarction. Danshen may enhance endogenous anti-oxidative enzyme activities such as the expression of endothelial nitric oxide synthase and may scavenge oxygen free radicals. Prevention and treatment of cerebral infarction by Danshen involves multiple pathways, including anti-atherosclerosis, anti-hypertension, anti-platelet aggregation, anti-inflammatory and anti-oxidative effects. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 1 | 20% |
China | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Scientists | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Chile | 1 | 3% |
Portugal | 1 | 3% |
Unknown | 38 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 7 | 18% |
Student > Bachelor | 6 | 15% |
Student > Ph. D. Student | 6 | 15% |
Researcher | 4 | 10% |
Student > Master | 3 | 8% |
Other | 5 | 13% |
Unknown | 9 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 20% |
Agricultural and Biological Sciences | 6 | 15% |
Medicine and Dentistry | 6 | 15% |
Biochemistry, Genetics and Molecular Biology | 3 | 8% |
Social Sciences | 2 | 5% |
Other | 3 | 8% |
Unknown | 12 | 30% |